Understanding how a specific protein affects the structure and function of the nucleolus in cells.

Uncovering novel players in nucleolar organization and function

NIH-funded research Ut Southwestern Medical Center · NIH-11061863

This study is looking at a protein called ZNF692 to understand how it helps keep a part of our cells, called the nucleolus, working properly, which is important for making ribosomes; the findings could help us learn more about diseases like Alzheimer's and cancer, potentially leading to better treatments.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center NIH-funded
Lab location1 site (Dallas, United States)
Project IDNIH-11061863 on NIH RePORTER

What this research studies

This research investigates the role of a protein called ZNF692 in maintaining the structure and function of the nucleolus, a key cellular organelle involved in producing ribosomes. By studying how ZNF692 interacts with other proteins and influences ribosome biogenesis, the research aims to uncover the molecular mechanisms that could be disrupted in diseases like Alzheimer's and cancer. Patients may benefit from insights gained about nucleolar defects and their implications for neurodegenerative disorders and cancer treatment.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related neurodegenerative disorders.

Not a fit: Patients with non-neurodegenerative conditions or those not affected by nucleolar dysfunction may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating Alzheimer's disease and other neurodegenerative conditions by targeting nucleolar dysfunction.

How similar studies have performed: Previous studies have shown that targeting nucleolar defects can have therapeutic potential in cancer and neurodegenerative diseases, suggesting that this approach may yield promising results.

Where this research is happening

Dallas, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseCancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.